| Unique ID issued by UMIN | UMIN000049174 |
|---|---|
| Receipt number | R000056011 |
| Scientific Title | Pre close versus post close using suture-mediated closure system for catheter ablation |
| Date of disclosure of the study information | 2024/10/01 |
| Last modified on | 2024/07/22 16:57:14 |
Pre close versus post close using suture-mediated closure system for catheter ablation
Pre close versus post close using suture-mediated closure system for catheter ablation
Pre close versus post close using suture-mediated closure system for catheter ablation
Pre close versus post close using suture-mediated closure system for catheter ablation
| Japan |
tachycardia
| Cardiology |
Others
NO
we conducted a prospective randomized study comparing the efficacy and safety of 2 different suture technique for femoral vein access using Perclose ProGlide (PC) suture-mediated closure system.
Safety,Efficacy
The primary efficacy endpoint was rebleeding rate requiring recompression during immobilization, bedrest and after ambulation. The primary safety endpoint is the incidence of major complications related to venous access site closure at 90days.
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Dose comparison
2
Treatment
| Maneuver |
Pre close
Post close
| 20 | years-old | <= |
| Not applicable |
Male and Female
participants included patients who were over 20 years old who underwent elective, nonemergent, catheter ablation via the common femoral veins using a 6-F to 13F inner diameter introducer sheath, a minimum of 2 and maximum of 4 femoral venous access sites, and a maximum of 3 access sites per leg were enrolled.
Exclusion criteria included vascular surgery or catheter ablation within the last three months, active systemic or cutaneous infection or inflammation in the vicinity of the groin, any preexisting immunodeficiency disorder, long term use of high dose systemic steroids,
history of bleeding diathesis, coagulopathy, hypercoagulability, or thromboembolic events, platelet count over 100,000 cells per mm, or severe comorbidities with life expectancy 12 months in the opinion of the site investigator. After providing informed consent, patients underwent the appropriate ablation procedure
280
| 1st name | Akio |
| Middle name | |
| Last name | Chikata |
Toyama Prefectural Central Hospital
Department of Cardiology
9308550
2-2-78 Nishi-nagae, Toyama
076-424-1531
akio.chbikata@gmail.com
| 1st name | Akio |
| Middle name | |
| Last name | Chikata |
Toyama Prefectural Central Hospital
Department of Cardiology
9308550
2-2-78 Nishi-nagae, Toyama
076-424-1531
akio.chbikata@gmail.com
Toyama Prefectural Central Hospital
Toyama Prefectural Central Hospital
Other
Toyama Prefectural Central Hospital
2-2-78 Nishi-nagae, Toyama
076-424-1531
byoin@esp.pref.toyama.lg.jp
NO
| 2024 | Year | 10 | Month | 01 | Day |
Unpublished
The primary efficacy endpoint was the number of rebleeding cases requiring recompression during immobilization and bed rest and after ambulation.
The primary safety endpoint was the incidence of major complications associated with venous access site closure.
Short-term efficacy endpoint and long-term outcomes related to the safety endpoint.
Open public recruiting
| 2022 | Year | 07 | Month | 24 | Day |
| 2022 | Year | 10 | Month | 05 | Day |
| 2022 | Year | 10 | Month | 05 | Day |
| 2024 | Year | 12 | Month | 31 | Day |
| 2022 | Year | 10 | Month | 10 | Day |
| 2024 | Year | 07 | Month | 22 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056011